Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Health-related quality of life in psoriatic arthritis patients in Spain.

Gratacós J, Daudén E, Gómez-Reino J, Moreno JC, Casado MÁ, Rodríguez-Valverde V.

Reumatol Clin. 2014 Jan-Feb;10(1):25-31. doi: 10.1016/j.reuma.2013.05.006. Epub 2013 Oct 5.

2.

Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis.

Klareskog L, Gaubitz M, Rodríguez-Valverde V, Malaise M, Dougados M, Wajdula J; Etanercept Study 301 Investigators.

Clin Exp Rheumatol. 2011 Mar-Apr;29(2):238-47. Epub 2011 Apr 19.

PMID:
21418785
3.

Vasculitis syndromes: Not losing sight is the issue in GCA management.

González-Gay MA, Rodríguez-Valverde V.

Nat Rev Rheumatol. 2010 Aug;6(8):440-1. doi: 10.1038/nrrheum.2010.119. No abstract available.

PMID:
20676123
4.

Interleukin-12 gene polymorphisim in patients with giant cell arteritis, polymyalgia rheumatica and elderly-onset rheumatoid arthritis.

Alvarez-Rodriguez L, Martínez-Taboada VM, López-Hoyos M, Mata C, Fernandez Prieto L, Agudo-Bilbao M, Calvo J, Ruiz Soto M, Rodriguez-Valverde V, Ruiz T, Blanco R, Corrales A, Carrasco-Marín E.

Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S14-8.

PMID:
19646340
5.

[Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis].

Tornero Molina J, Sanmartí Sala R, Rodríguez Valverde V, Martín Mola E, Marenco de la Fuente JL, González Álvaro I, Muñoz Fernández S, Gómez-Reino Carnota J, Carreño Pérez L, Batlle Gualda E, Balsa Criado A, Andreu JL, Alvaro-Gracia JM, Martínez López JA, Loza Santamaría E.

Reumatol Clin. 2010 Jan-Feb;6(1):23-36. doi: 10.1016/j.reuma.2009.10.006. Epub 2009 Dec 6. Spanish.

6.

[Adult-onset Still's disease with liver failure requiring liver transplantation].

Terán A, Casafont F, Fábrega E, Martínez-Taboada VM, Rodríguez-Valverde V, Pons-Romero F.

Gastroenterol Hepatol. 2009 Dec;32(10):681-6. doi: 10.1016/j.gastrohep.2009.06.009. Epub 2009 Sep 27. Review. Spanish.

PMID:
19783075
7.

Cloxacillin-based therapy in severe septic bursitis: retrospective study of 82 cases.

Martinez-Taboada VM, Cabeza R, Cacho PM, Blanco R, Rodriguez-Valverde V.

Joint Bone Spine. 2009 Dec;76(6):665-9. doi: 10.1016/j.jbspin.2009.04.003.

PMID:
19576835
8.

The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial.

Schiff M, Pritchard C, Huffstutter JE, Rodriguez-Valverde V, Durez P, Zhou X, Li T, Bahrt K, Kelly S, Le Bars M, Genovese MC.

Ann Rheum Dis. 2009 Nov;68(11):1708-14. doi: 10.1136/ard.2008.099218. Epub 2008 Dec 15.

9.

Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: Association of IL-1RN*2/2 genotype with polymyalgia rheumatica.

Alvarez-Rodriguez L, Carrasco-Marin E, Lopez-Hoyos M, Mata C, Fernandez-Prieto L, Ruiz-Soto M, Calvo J, Rodriguez-Valverde V, Ruiz T, Blanco R, Corrales A, Martinez-Taboada VM.

Hum Immunol. 2009 Jan;70(1):49-54. doi: 10.1016/j.humimm.2008.10.011. Epub 2008 Nov 19.

PMID:
19026700
10.

A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.

Martínez-Taboada VM, Rodríguez-Valverde V, Carreño L, López-Longo J, Figueroa M, Belzunegui J, Mola EM, Bonilla G.

Ann Rheum Dis. 2008 May;67(5):625-30. Epub 2007 Dec 17.

PMID:
18086726
11.

Recall injection-site reactions associated with etanercept therapy: report of two new cases with immunohistochemical analysis.

González-López MA, Martínez-Taboada VM, González-Vela MC, Blanco R, Fernández-Llaca H, Rodríguez-Valverde V, Val-Bernal JF.

Clin Exp Dermatol. 2007 Nov;32(6):672-4.

PMID:
17953638
12.

Performance of antinuclear antibody connective tissue disease screen.

López-Hoyos M, Rodríguez-Valverde V, Martinez-Taboada V.

Ann N Y Acad Sci. 2007 Aug;1109:322-9.

PMID:
17785321
13.

Atypical scabies in systemic lupus erythematosus.

Val-Bernal JF, Gonzalez-Vela MC, Yanez S, Mira C, Martinez-Taboada V, Rodriguez-Valverde V.

Ann Saudi Med. 1998 Nov-Dec;18(6):534-6. No abstract available.

14.

Development of sarcoidosis during etanercept therapy.

González-López MA, Blanco R, González-Vela MC, Fernández-Llaca H, Rodríguez-Valverde V.

Arthritis Rheum. 2006 Oct 15;55(5):817-20. Review. No abstract available.

15.

Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.

Martínez-Taboada VM, Val-Bernal JF, Pesquera LC, Fernández-Llanio NE, Esteban JM, Blanco R, Alonso-Bartolome P, Gonzalez-Vela C, Rodríguez-Valverde V.

Scand J Rheumatol. 2006 Jul-Aug;35(4):322-3. No abstract available.

PMID:
16882599
16.

Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis.

Garcia-Unzueta MT, Martínez-Taboada VM, Amado-Señarís JA, Rodríguez-Valverde V.

Clin Exp Rheumatol. 2006 Mar-Apr;24(2 Suppl 41):S6-9.

PMID:
16859588
17.

Hypertrophic osteoarthropathy secondary to vascular prosthesis infection: report of 3 cases and review of the literature.

Alonso-Bartolomé P, Martínez-Taboada VM, Pina T, Blanco R, Rodriguez-Valverde V.

Medicine (Baltimore). 2006 May;85(3):183-91. Review.

18.

Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.

van der Heijde D, Klareskog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J, Tornero-Molina J, Wajdula J, Pedersen R, Fatenejad S; TEMPO Study Investigators.

Arthritis Rheum. 2006 Apr;54(4):1063-74.

19.

A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs.

Klareskog L, Gaubitz M, Rodriguez-Valverde V, Malaise M, Dougados M, Wajdula J; Etanercept Study 301 Investigators.

Ann Rheum Dis. 2006 Dec;65(12):1578-84. Epub 2006 Mar 15.

20.

III Actualización del Consenso de la Sociedad Española de Reumatología sobre terapia biológica en la artritis reumatoide.

Rodríguez-Valverde V, Cáliz Cáliz R, Alvaro-Gracia Álvaro JM, Marenco de la Fuente JL, Mulero Mendoza J, Tornero Molina J, Andréu Sánchez JL, Ballina García FJ, Batlle Gualda E, Cañete Crespillo JD, Carbonell Abelló J, Carreño Pérez L, Figueroa Pedrosa M, Gómez-Reino Carnota J, González García T, Laffon Roca A, Martín Mola E, Pascual Gómez E, Sanmartí Sala R, Salazar Vallinas JM, Valverde García J.

Reumatol Clin. 2006 Mar;2 Suppl 2:S52-9. doi: 10.1016/S1699-258X(06)73097-2. Epub 2008 Dec 10. Spanish. No abstract available.

21.

Clinical disease activity and titers of anti-dsDNA antibodies measured by an automated immunofluorescence assay in patients with systemic lupus erythematosus.

López-Hoyos M, Cabeza R, Martínez-Taboada VM, Crespo J, SanSegundo D, Blanco R, López-Escribano H, Peña M, Rodríguez-Valverde V.

Lupus. 2005;14(7):505-9.

PMID:
16130504
22.

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.

Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, Montero D, Pascual-Gómez E, Mola EM, Carreño L, Figueroa M; BIOBADASER Group.

Arthritis Rheum. 2005 Jun;52(6):1766-72.

23.

Outcome of late-onset rheumatoid arthritis.

Calvo-Alén J, Corrales A, Sánchez-Andrada S, Fernández-Echevarría MA, Peña JL, Rodríguez-Valverde V.

Clin Rheumatol. 2005 Sep;24(5):485-9. Epub 2005 Mar 5.

PMID:
15750680
24.

Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study.

van der Heijde D, Landewé R, Klareskog L, Rodríguez-Valverde V, Settas L, Pedersen R, Fatenejad S.

Arthritis Rheum. 2005 Jan;52(1):49-60.

25.

Pulmonary hypertension in a patient with rheumatoid arthritis treated with leflunomide.

Martinez-Taboada VM, Rodriguez-Valverde V, Gonzalez-Vilchez F, Armijo JA.

Rheumatology (Oxford). 2004 Nov;43(11):1451-3. No abstract available.

PMID:
15501999
26.

HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis.

Martínez-Taboda VM, Bartolome MJ, Lopez-Hoyos M, Blanco R, Mata C, Calvo J, Corrales A, Rodriguez-Valverde V.

Semin Arthritis Rheum. 2004 Aug;34(1):454-64.

PMID:
15305244
27.

Clinical utility of antibodies to double-stranded DNA by a new immunofluorescence test.

López-Hoyos M, Ayerbe I, Martínez-Taboada VM, Bartolomé MJ, Blanco R, López-Escribano H, Peña M, Rodríguez-Valverde V.

Lupus. 2004;13(2):144-7. No abstract available.

PMID:
14995011
28.

Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica.

Lopez-Hoyos M, Ruiz de Alegria C, Blanco R, Crespo J, Peña M, Rodriguez-Valverde V, Martinez-Taboada VM.

Rheumatology (Oxford). 2004 May;43(5):655-7. Epub 2004 Feb 17.

PMID:
14970400
29.

Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.

Lopez-Hoyos M, Bartolome-Pacheco MJ, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM.

Ann Rheum Dis. 2004 Jan;63(1):54-60.

30.

Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry.

Calvo-Alén J, Reveille JD, Rodríguez-Valverde V, McGwin G Jr, Baethge BA, Friedman AW, Alarcón GS.

Lupus. 2003;12(5):377-85.

PMID:
12765301
31.

Functional outcome and subset identification in RA patients from meridional Europe: analysis of a Spanish cohort.

Calvo-Alén J, Corrales A, Sánchez-Andrada S, Fernández-Echevarría MA, Peña JL, Rodriguez-Valverde V.

Clin Rheumatol. 2003 May;22(2):77-83.

PMID:
12740668
32.

Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.

Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M.

Rheumatology (Oxford). 2003 Sep;42(9):1055-61. Epub 2003 Apr 16.

PMID:
12730520
33.

Hypothalamic-pituitary-adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis.

Pacheco MJ, Amado JA, Lopez-Hoyos M, Blanco R, Garcia-Unzueta MT, Rodriguez-Valverde V, Martinez-Taboada VM.

Semin Arthritis Rheum. 2003 Feb;32(4):266-72.

PMID:
12621591
34.

Changes in peripheral blood lymphocyte subsets in elderly subjects are associated with an impaired function of the hypothalamic-pituitary-adrenal axis.

Martínez-Taboada V, Bartolomé MJ, Amado JA, Blanco R, García-Unzueta MT, Rodríguez-Valverde V, López-Hoyos M.

Mech Ageing Dev. 2002 Sep;123(11):1477-86.

PMID:
12425955
35.

Reactive arthritis after BCG immunotherapy: T cell analysis in peripheral blood and synovial fluid.

Bartolome Pacheco MJ, Martinez-Taboada VM, Blanco R, Rodriguez-Valverde V, Valle JI, Lopez-Hoyos M.

Rheumatology (Oxford). 2002 Oct;41(10):1119-25.

PMID:
12364630
36.

[Rheumatoid arthritis: Something important has changed].

Pascual Gómez E, Rodríguez Valverde V.

Med Clin (Barc). 2002 Mar 2;118(7):262-4. Spanish. No abstract available.

PMID:
11882279
37.

Mycotic (infected) aneurysm of the popliteal artery and arthritis following Salmonella bacteriemia.

Alonso-Bartolomé P, Alonso Valle H, Aurrecoechea E, Acha O, Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V.

Clin Exp Rheumatol. 2001 May-Jun;19(3):325-8.

PMID:
11407089
38.

Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis.

Bartolome MJ, Martínez-Taboda VM, Lopez-Hoyos M, Blanco R, Rodriguez-Valverde V.

Clin Exp Rheumatol. 2001 May-Jun;19(3):259-64.

PMID:
11407077
39.

Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.

Martinez-Taboada VM, Blanco R, Fito C, Pacheco MJ, Delgado-Rodriguez M, Rodriguez-Valverde V.

Semin Arthritis Rheum. 2001 Feb;30(4):257-71. Review.

PMID:
11182026
40.

Haematogenous vertebral osteomyelitis in the elderly.

Belzunegui J, Intxausti JJ, De Dios JR, Del Val N, Rodríguez Valverde V, González C, Queiro R, Figueroa M.

Clin Rheumatol. 2000;19(5):344-7.

PMID:
11055821
41.

Polymyalgia rheumatica with normal erythrocyte sedimentation rate: clinical aspects.

Martínez-Taboada VM, Blanco R, Rodríguez-Valverde V.

Clin Exp Rheumatol. 2000 Jul-Aug;18(4 Suppl 20):S34-7. Review.

PMID:
10948758
42.

[Rheumatoid arthritis. Biologic treatments].

Rodríguez-Valverde V.

Rev Clin Esp. 2000 May;200 Monog 1:107-13. Review. Spanish. No abstract available.

PMID:
10901035
43.

Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis.

Smolen JS, Breedveld FC, Burmester GR, Combe B, Emery P, Kalden JR, Klareskog L, Maini RN, Numo R, van De Putte LB, van Riel PL, Rodriguez-Valverde V.

Ann Rheum Dis. 2000 Jul;59(7):504-5. Review. No abstract available.

44.

Giant cell arteritis with an erythrocyte sedimentation rate lower than 50.

Martínez-Taboada VM, Blanco R, Armona J, Uriarte E, Figueroa M, Gonzalez-Gay MA, Rodriguez-Valverde V.

Clin Rheumatol. 2000;19(1):73-5.

PMID:
10752506
45.

Vertebral osteomyelitis in northern Spain. Report of 62 cases.

Belzunegui J, Del Val N, Intxausti JJ, De Dios JR, Queiro R, González C, Rodríguez-Valverde V, Figueroa M.

Clin Exp Rheumatol. 1999 Jul-Aug;17(4):447-52.

PMID:
10464555
46.

Insufficiency fractures of the tibia and fibula.

Alonso-Bartolomé P, Martínez-Taboada VM, Blanco R, Rodriguez-Valverde V.

Semin Arthritis Rheum. 1999 Jun;28(6):413-20.

PMID:
10406409
47.

Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients.

Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V, García-Fuentes M.

Medicine (Baltimore). 1998 Nov;77(6):403-18. Review.

48.

Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.

González-Gay MA, Blanco R, Rodríguez-Valverde V, Martínez-Taboada VM, Delgado-Rodriguez M, Figueroa M, Uriarte E.

Arthritis Rheum. 1998 Aug;41(8):1497-504.

PMID:
9704651
49.

Survival analysis of 306 European Spanish patients with systemic lupus erythematosus.

Blanco FJ, Gómez-Reino JJ, de la Mata J, Corrales A, Rodríguez-Valverde V, Rosas JC, Gómez de la Camara A, Pascual E.

Lupus. 1998;7(3):159-63.

PMID:
9607639
50.

Long-term outcome of total lymphoid irradiation in rheumatoid arthritis: comment on the article by Westhovens et al.

Blanco R, Sánchez-Andrada S, Martínez-Taboada V, Peña Sagredo JL, Rodríguez-Valverde V.

Arthritis Rheum. 1998 May;41(5):945-6. No abstract available.

PMID:
9588751

Supplemental Content

Loading ...
Support Center